http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2135870-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_24aca9ded2638ea793d05360dde7a4a0
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-14
filingDate 2008-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2012-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_021bf9e4fb6f327fd320976eb0b139c3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4d9cb29d77c9d38ea34786b213402555
publicationDate 2012-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-2135870-B1
titleOfInvention Process for production of mirtazapine
abstract The invention provides a process for the production of mirtazapine by which high-purity mirtazapine which is safely usable as drug can be simply and easily obtained from a reaction fluid obtained by ring-closing reaction of 2-(4-methyl-2 -phenylpiperazin-1-yl)pyridine-3-methanol with concentrated sulfuric acid. A process for the production of mirtazapine, characterized by subjecting a reaction fluid obtained by ring-closing reaction of 2-(4-methyl-2-phenylpiperazin -1-yl)pyridine-3-methanol with concentrated sulfuric acid to dilution with water, alkalizing the obtained dilution in the presence of propanol to extract mirtazapine into the propanol, and crystallizing mirtazapine from the resulting extract.
priorityDate 2007-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227944997
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8174
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128988724
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227547528
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468385360
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426156635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8900
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1031
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226410879
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID228702417
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID524183
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412584819
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450423205
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10221435
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1118
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128657535
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558802
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129159156
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22263336
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454356204
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419495549
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67472762
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67472763
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21702714
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID228702420
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485854
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226421655
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4205
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129198707

Total number of triples: 46.